B95.62 vs Z16.12
B95.62 (Methicillin resistant Staphylococcus aureus infection as the cause of diseases classified elsewhere) compared with Z16.12 (Extended spectrum beta lactamase (ESBL) resistance), from the official CMS tabular data. Both may be reported when both conditions are documented (Excludes2).
Can these codes be reported together?
Yes, when both are documented. Z16.12 carries an Excludes2 note covering B95.62: “Methicillin resistant Staphylococcus aureus infection in diseases classified elsewhere (B95.62)”
Excludes2 marks distinct conditions — both may be reported when both are documented.
Side by side
| B95.62Methicillin resistant Staphylococcus aureus infection as the cause of diseases classified elsewhere | Z16.12Extended spectrum beta lactamase (ESBL) resistance | |
|---|---|---|
| Billing status | Billable | Billable |
| Classification | A00-B99 — Certain Infectious and Parasitic Diseases (A00-B99) | Z00-Z99 — Factors Influencing Health Status and Contact with Health Services (Z00-Z99) |
| Definition | Methicillin resistant Staphylococcus aureus infection as the cause of diseases classified elsewhere is a billable ICD-10-CM diagnosis code (B95.62). | Extended spectrum beta lactamase (ESBL) resistance is a billable ICD-10-CM diagnosis code (Z16.12). |
| Includes | Methicillin resistant staphylococcus aureus (MRSA) infection as the cause of diseases classified elsewhere | — |
| Code first | — | the infection |
Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources